₹ 2.4 Cr
Volume Transacted
(Nov 21, 2024)
185.2 K
Stocks Traded
(Nov 21, 2024)
Last Updated on: Nov 22, 2024
Bliss GVS Pharma Ltd
NSE: BLISSGVS
EPS
₹ 7.99
Last updated on: Nov 21, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Historical Earning per Share of Bliss GVS Pharma Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
No data available
* All values are in ₹
Market Cap
₹ 1,358 Cr
EPS
₹ 8.0
P/E Ratio (TTM) *
16.1
P/B Ratio (TTM) *
1.4
Day’s High *
131.4
Day’s Low
₹ 120.15
DTE *
0.1
ROE *
8.3
52 Week High
₹ 148.95
52 Week Low
₹ 92.25
ROCE *
12.7
* All values are consolidated
Last Updated time: 22 Nov 9.00 AM
* All values are consolidated
Last Updated time: 22 Nov 9.00 AM
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
21 Nov 2024 | 129 | 120.15 | 131.4 | 120.15 |
19 Nov 2024 | 120.75 | 121 | 124.65 | 120.1 |
18 Nov 2024 | 121.65 | 120.3 | 123.25 | 113.6 |
14 Nov 2024 | 117.95 | 118 | 118.85 | 115.8 |
13 Nov 2024 | 116.35 | 121.9 | 121.9 | 114.35 |
12 Nov 2024 | 118.7 | 120.1 | 123.25 | 117.9 |
11 Nov 2024 | 121.2 | 124.05 | 124.05 | 121 |
08 Nov 2024 | 124.15 | 126.15 | 128.6 | 123.55 |
07 Nov 2024 | 126.55 | 129.45 | 131.15 | 126.25 |
06 Nov 2024 | 129.2 | 122.7 | 131.55 | 122.7 |
Date | Price (₹) |
---|---|
21 Nov 2024 | 129 |
19 Nov 2024 | 120.75 |
18 Nov 2024 | 121.65 |
14 Nov 2024 | 117.95 |
13 Nov 2024 | 116.35 |
12 Nov 2024 | 118.7 |
11 Nov 2024 | 121.2 |
08 Nov 2024 | 124.15 |
07 Nov 2024 | 126.55 |
06 Nov 2024 | 129.2 |
Strength
2
S
Weakness
1
W
Opportunity
0
O
Threats
1
T
Revenue
Profitability
Affordability
Liquidity
Dividend
Market Value
₹ 1,358
Asset Value
₹ 835
0.6 X
Value addition
* All values are in Rupees
Company Name | EPS | Market Cap (INR Cr.) |
---|---|---|
Bliss GVS Pharma Ltd | 7 | 1,358 |
Sun Pharmaceuticals Industries Ltd | 46 | 4,26,518 |
Divis Laboratories Ltd | 69 | 1,58,636 |
Cipla Ltd | 57 | 1,18,365 |
Torrent Pharmaceuticals Ltd | 51 | 1,05,067 |
Mankind Pharma Ltd | 52 | 1,02,273 |
Historical Market Cap of Bliss GVS Pharma Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
No data available
* All values are in ₹ crore
Historical Revenue of Bliss GVS Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical EBITDA of Bliss GVS Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Historical Net Profit of Bliss GVS Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
No data available
Bliss GVS Pharma to table results
Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 Octobe...
18 Oct 202410:48
Bliss GVS Pharma allots 1.57 lakh equity shares under ESOP
Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With th...
04 Oct 202418:37
Bliss GVS Pharma to convene board meeting
Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 July 2...
18 Jul 202411:35
Bliss GVS Pharma to convene AGM
Bliss GVS Pharma announced that the 39th Annual General Meeting(AGM) of the company will b...
04 May 202416:04
Board of Bliss GVS Pharma recommends final dividend
Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held ...
03 May 202410:36
Bliss GVS Pharma announces board meeting date
Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 2 May 202...
26 Apr 202411:02
Unlimited trading at just
Rs. 199*